Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, ...

Ever since its early roots, the US has been a key player in the pharmaceutical industry, with prominent names like Pfizer, Eli Lilly and Bristol Myers Squibb (BMS) all becoming market pioneers in the ...

In 2025 it seemed the only certainty for biotech was more uncertainty. Biotech leaders conducted business as usual against ...

Washington and Wall Street have spent decades debating U.S. dependence on China for chips, consumer electronics and manufacturing. Now, China is poised to disrupt another major industry, one that is ...

CARVYKTI- (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full year 2025, respectivelySurpassed milestone of more than ...

"We are also seeing improvement in US biotech funding, as well as higher M&A and IPO activity, which are leading indicators ...

The new year has ushered in a flow of biotech-specific funds, including $700 million from Andreessen Horowitz (A16z). The Silicon Valley-based venture capitalist announced $15 billion raised across ...

A hand holds up a tamper-safe orange bottle filled with oblong white pills against a red-tinted background of Chinese yuan. As China’s biopharmaceutical industry churns out more innovative molecules, ...